{
    "clinical_study": {
        "@rank": "67314", 
        "arm_group": [
            {
                "arm_group_label": "American Heart Association diet", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants randomized into this arm will follow an American Heart Association diet plan for 8 weeks."
            }, 
            {
                "arm_group_label": "Whole-food plant-based vegan diet", 
                "arm_group_type": "Experimental", 
                "description": "Participants randomized into this arm will be asked to follow a whole-food plant-based vegan diet plan for 8 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "In this randomized study the investigators aim to determine the effects of a whole-food\n      plant-based vegan diet on markers of inflammation and glucometabolic profile in patients\n      with cardiovascular disease. The investigators hypothesize that a whole-food plant-based\n      vegan diet will reduce markers of inflammation and improve glucometabolic profile compared\n      with the American Heart Association (AHA)- recommended diet at 2 months follow-up in\n      patients after percutaneous coronary intervention (PCI). The investigators are also\n      evaluating endothelial function using the EndoPAT device and stool microbiome."
        }, 
        "brief_title": "Vegan vs AHA Diet on Inflammation and Glucometabolic Profile After PCI", 
        "condition": [
            "Coronary Artery Disease", 
            "Inflammation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Inflammation"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects on stable medical therapy for at least 7-10 days post-PCI.\n\n        Exclusion Criteria:\n\n          -  Failure of the Treatment Self-Regulation Questionnaire\n\n          -  Use of steroids or non-steroidal anti-inflammatory medications other than aspirin\n\n          -  Use of probiotics or over the counter supplements other than standard vitamins\n\n          -  Have a history of myocardial infarction or active infection within the preceding 3\n             months\n\n          -  Have a history of an eating disorder or colon cleansing or are already on a\n             whole-food plant-based vegan diet\n\n          -  Have a planned PCI during the study period\n\n          -  Are participating in a competing study\n\n          -  Have any condition or situation that, in the investigator's opinion, may confound the\n             study results, or may interfere significantly with the patient's ability to adhere\n             with study procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02135939", 
            "org_study_id": "S14-00292"
        }, 
        "intervention": {
            "arm_group_label": [
                "American Heart Association diet", 
                "Whole-food plant-based vegan diet"
            ], 
            "intervention_name": "Diet", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 8, 2014", 
        "location": {
            "contact": {
                "email": "binita.shah@nyumc.org", 
                "last_name": "Binita Shah, MD, MS", 
                "phone": "212-263-4235"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10016"
                }, 
                "name": "NYUMC Tisch Hospital, HCC 14"
            }, 
            "investigator": [
                {
                    "last_name": "Binita Shah, MD, MS", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Jonathan Newman, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "James Slater, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of a Whole-food Plant-based Vegan Diet on Markers of Inflammation and Glucometabolic Profile After Percutaneous Coronary Intervention", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: NYUSOM Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "change in hsCRP from baseline", 
            "safety_issue": "No", 
            "time_frame": "At 8 weeks follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02135939"
        }, 
        "responsible_party": {
            "investigator_affiliation": "New York University School of Medicine", 
            "investigator_full_name": "Binita Shah", 
            "investigator_title": "Instructor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "change in L-selectin from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in body mass index from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in Abdominal Circumference from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in Blood Pressure from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in CD11b from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change  in Stool microbiome from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 and 8 week follow-up"
            }, 
            {
                "measure": "change in EndPAT score from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 and 8 week follow-up"
            }, 
            {
                "description": "soluble inflammatory marker", 
                "measure": "change in Serum amyloid A from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in TNF-\u03b1 from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in pentraxin-3 from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in MMP-9 from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in lipid panel from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in apolipoprotein B from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in fasting blood glucose from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in blood insulin from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in Hemoglobin a1c from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in cell adhesion molecule from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in monocyte subtype from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in interleukin from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }, 
            {
                "measure": "change in chemokine from baseline", 
                "safety_issue": "No", 
                "time_frame": "4 week and 8 week follow-up"
            }
        ], 
        "source": "New York University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "New York University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}